טוען...

Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation

Dendritic cell (DC)–based immunotherapies are believed to help eradicate residual tumor cells, including hepatocellular carcinoma (HCC). Here, we assessed the safety and clinical response to OK432-stimulated monocyte-derived DCs (MoDCs) in treating HCC after radiofrequency ablation (RFA). MoDCs were...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Transl Oncol
Main Authors: Kitahara, Masaaki, Mizukoshi, Eishiro, Terashima, Takeshi, Nakagawa, Hidetoshi, Horii, Rika, Iida, Noriho, Arai, Kuniaki, Yamashita, Taro, Sakai, Yoshio, Yamashita, Tatsuya, Honda, Masao, Nakamoto, Yasunari, Kaneko, Shuichi
פורמט: Artigo
שפה:Inglês
יצא לאור: Neoplasia Press 2020
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226894/
https://ncbi.nlm.nih.gov/pubmed/32413834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100777
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!